Covid-19

China is set to announce an easing of its COVID-19 quarantine protocols in the coming days and a reduction in mass testing, sources told Reuters, a marked shift in policy after anger over the world's…

OPEC+ is likely to keep oil output policy unchanged at a meeting on Sunday, five OPEC+ sources said, although two sources said an additional production cut was also likely to be considered to bolster…

Chinese authorities have begun inquiries into some of the people who gathered at weekend protests against COVID-19 curbs, people who were at the Beijing demonstrations told Reuters, as police…

Oil prices jumped by 3% on Tuesday on hopes for a relaxation of China's strict COVID-19 controls after rare protests in Chinese cities over the weekend. Brent crude futures gained $2.50, or 3%, to…

Frustration simmered on Friday among residents and business groups in China navigating stricter COVID-19 control curbs as the country reported another record high of daily infections just weeks after…

An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot…

Updated COVID-19 boosters offer increased protection against new variants in people who have previously received up to four doses of the older vaccine, a real-world study in the United States showed…

Chinese authorities faced more public anger Thursday after a second child’s death was blamed on overzealous anti-virus enforcement, adding to frustration at controls that are confining millions of…

Bali wants the world to know it’s back. Dozens of world leaders and other dignitaries are traveling to the Indonesian island for the G-20 summit, drawing a welcome spotlight on the revival of the…

The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID,…